NeW

J&J plans to seek approval soon for key new drugs

AP News
|
Posted: May 26, 2011 5:34 PM
J&J plans to seek approval soon for key new drugs

Some key prescription drugs for which Johnson & Johnson expects to seek approval by 2015:

_Bapineuzumab, injection to slow progress of Alzheimer's disease.

_Canagliflozin, for Type 2 diabetes.

_Sirukumab, injection for rheumatoid arthritis.

_Fulranumab, injection for pain caused by osteoarthritis or nerve problems.

_TMC 207, or multi-drug-resistant tuberculosis.

_TMC 435, for hepatitis C.

_FlumAb, injection for respiratory infections.

_FluCell, influenza vaccine.